SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-272398 from CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)

CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)
Date: Nov. 7, 2023 · CIK: 0001966494 · Accession: 0001193125-23-272398

AI Filing Summary & Sentiment

File numbers found in text: 333-275113

Date
November 9, 2023
Author
By
Form
CORRESP
Company
CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)

Letter

CARGO Therapeutics, Inc.

1900 Alameda De Las Pulgas, Suite 350

San Mateo, California 94403

November 7,

VIA EDGAR AND E-MAIL

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention: Christine Torney

Mary Mast

Jimmy McNamara

Tim Buchmiller

Re: CARGO Therapeutics, Inc. Registration Statement on Form S-1 (Registration No. 333-275113)

To the addresses set forth above:

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (Registration No. 333-275113) (the “Registration Statement”) of CARGO Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on November 9, 2023, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Phillip Stoup at (415) 395-8216 or Benjamin A. Potter at (650) 470-4809.

Thank you for your assistance in this matter.

Sincerely,
CARGO THERAPEUTICS, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 CARGO Therapeutics, Inc.

1900 Alameda De Las Pulgas, Suite 350

San Mateo, California 94403

 November 7,
2023

 VIA EDGAR AND E-MAIL

United States Securities and Exchange Commission

 Division of
Corporation Finance

 Office of Life Sciences

 100 F Street,
N.E.

 Washington, D.C. 20549-6010

Attention:
 Christine Torney

 
 Mary Mast

 
 Jimmy McNamara

 
 Tim Buchmiller

Re:  
 CARGO Therapeutics, Inc. Registration Statement on Form S-1
(Registration No. 333-275113)

 To the addresses set forth above:

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby
request acceleration of the effective date of the Registration Statement on Form S-1 (Registration No. 333-275113) (the “Registration
Statement”) of CARGO Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on November 9, 2023, or as soon as
practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Phillip Stoup at (415) 395-8216
or Benjamin A. Potter at (650) 470-4809.

 Thank you for your assistance in this matter.

Sincerely,

CARGO THERAPEUTICS, INC.

By:

/s/ Gina Chapman

Gina Chapman

Chief Executive Officer

cc:
 Anup Radhakrishnan, CARGO Therapeutics, Inc.

Halley Gilbert, CARGO Therapeutics, Inc.

Benjamin A. Potter, Latham & Watkins LLP

B. Shayne Kennedy, Latham & Watkins LLP

Phillip S. Stoup, Latham & Watkins LLP

Denny Won, Cooley LLP

 Charles S.
Kim, Cooley LLP

 Kristin VanderPas, Cooley LLP

Dave Peinsipp, Cooley LLP